MEDP - Medpace Holdings, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
Cincinnati,
United States
Type: Equity
MEDP price evolution
MEDP
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $510.89 | $407.01 | $245.45 | |
| Short term investments | ||||
| Net receivables | $311.47 | $301.11 | $279.17 | $298.4 |
| Inventory | ||||
| Total current assets | $1032.6 | $872.52 | $744.9 | $593.83 |
| Long term investments | ||||
| Property, plant & equipment | $254.6 | $256.39 | $257.4 | $265.39 |
| Goodwill & intangible assets | $697.48 | $697.84 | $698.21 | |
| Total noncurrent assets | $1047.53 | $1050.89 | $1063 | |
| Total investments | ||||
| Total assets | $2084.06 | $1920.05 | $1795.79 | $1656.83 |
| Current liabilities | ||||
| Accounts payable | $26.2 | $27.39 | $24.4 | $31.87 |
| Deferred revenue | $638.42 | $616.7 | $559.86 | |
| Short long term debt | ||||
| Total current liabilities | $1041.35 | $993.09 | $956.64 | $925.13 |
| Long term debt | $131.8 | $136.16 | $142.12 | |
| Total noncurrent liabilities | $163.36 | $167.6 | $172.75 | |
| Total debt | $131.8 | $136.16 | $142.12 | |
| Total liabilities | $1202.62 | $1156.45 | $1124.25 | $1097.88 |
| Shareholders' equity | ||||
| Retained earnings | $65.64 | -$30.79 | -$119.14 | -$221.65 |
| Other shareholder equity | -$9.18 | -$12.59 | -$12.04 | -$10.07 |
| Total shareholder equity | $763.6 | $671.54 | $558.95 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $245.45 | $28.27 | $461.3 | $277.77 |
| Short term investments | ||||
| Net receivables | $298.4 | $253.4 | $186.43 | $160.96 |
| Inventory | ||||
| Total current assets | $593.83 | $333.96 | $690.91 | $473.65 |
| Long term investments | ||||
| Property, plant & equipment | $265.39 | $248.92 | $222.71 | $198.83 |
| Goodwill & intangible assets | $698.21 | $700.4 | $703.76 | $708.87 |
| Total noncurrent assets | $1063 | $1018.53 | $969.02 | $917.03 |
| Total investments | ||||
| Total assets | $1656.83 | $1352.49 | $1659.93 | $1390.68 |
| Current liabilities | ||||
| Accounts payable | $31.87 | $33.07 | $25.68 | $26.55 |
| Deferred revenue | $559.86 | $462.73 | $344.64 | $255.66 |
| Short long term debt | $50 | |||
| Total current liabilities | $925.13 | $803.47 | $557.22 | $440.11 |
| Long term debt | $142.12 | $138.87 | $130.97 | $115.14 |
| Total noncurrent liabilities | $172.75 | $162.64 | $149.79 | $144.79 |
| Total debt | $142.12 | $188.87 | $130.97 | $115.14 |
| Total liabilities | $1097.88 | $966.11 | $707.01 | $584.9 |
| Shareholders' equity | ||||
| Retained earnings | -$221.65 | -$359.83 | $234.98 | $115.23 |
| Other shareholder equity | -$10.07 | -$12.39 | -$4.85 | -$0.13 |
| Total shareholder equity | $558.95 | $386.39 | $952.93 | $805.78 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $533.32 | $528.1 | $498.4 | |
| Cost of revenue | $374.27 | $361.6 | ||
| Gross Profit | $169.01 | $153.84 | $136.81 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $41.45 | $42.51 | ||
| Total operating expenses | $56.73 | $48.69 | $49.49 | |
| Operating income | $105.15 | $87.32 | ||
| Income from continuing operations | ||||
| EBIT | $105.02 | $88.86 | ||
| Income tax expense | $22.35 | $22.13 | $12.41 | |
| Interest expense | $7.53 | -$5.46 | -$1.84 | |
| Net income | ||||
| Net income | $96.43 | $88.35 | $78.3 | |
| Income (for common shares) | $88.35 | $78.3 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1885.84 | $1460 | $1142.38 | $925.92 |
| Cost of revenue | $1361.34 | $1027.56 | $814.22 | $647.2 |
| Gross Profit | $524.5 | $432.44 | $328.15 | $278.73 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $161.35 | $131.4 | $108.42 | $92.16 |
| Total operating expenses | $187.68 | $153.74 | $129.54 | $111.68 |
| Operating income | $336.82 | $278.7 | $198.62 | $167.04 |
| Income from continuing operations | ||||
| EBIT | $336.17 | $285.76 | $201.96 | $168.22 |
| Income tax expense | $52.87 | $37.49 | $20 | $23.15 |
| Interest expense | $0.49 | $2.9 | $0.1 | -$0.31 |
| Net income | ||||
| Net income | $282.81 | $245.37 | $181.85 | $145.38 |
| Income (for common shares) | $282.81 | $245.37 | $181.85 | $145.38 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $88.35 | $102.59 | $78.3 | |
| Operating activities | ||||
| Depreciation | $13 | $12.69 | $12.04 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.59 | $4.31 | $5.17 | |
| Total cash flows from operations | $116.4 | $152.68 | $156.4 | |
| Investing activities | ||||
| Capital expenditures | -$12.87 | -$5.5 | -$9.99 | |
| Investments | ||||
| Total cash flows from investing | -$20.75 | -$12.79 | $2.53 | -$8 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.67 | $7.66 | $1.52 | |
| Net borrowings | ||||
| Total cash flows from financing | $14.6 | $0.67 | $7.66 | $1.52 |
| Effect of exchange rate | -$0.55 | -$0.39 | -$1.31 | $0.32 |
| Change in cash and equivalents | $411.45 | $103.88 | $161.56 | $150.24 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $282.81 | $245.37 | $181.85 | $145.38 |
| Operating activities | ||||
| Depreciation | $45.97 | $40.36 | $37.41 | $33.45 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $20.52 | $21.41 | $14.47 | $13.78 |
| Total cash flows from operations | $433.37 | $388.05 | $263.33 | $258.68 |
| Investing activities | ||||
| Capital expenditures | -$36.65 | -$36.88 | -$28.27 | -$31.34 |
| Investments | ||||
| Total cash flows from investing | -$34.63 | -$38.74 | -$31.36 | -$31.21 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$132.64 | -$825.77 | -$44.45 | -$82.28 |
| Net borrowings | -$50 | $50 | ||
| Total cash flows from financing | -$182.64 | -$775.77 | -$44.45 | -$82.28 |
| Effect of exchange rate | $1.08 | -$6.57 | -$3.97 | $0.67 |
| Change in cash and equivalents | $217.18 | -$433.04 | $183.54 | $145.85 |
News
Fundamentals
| Market cap | $10.55B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 31.01M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 8.29% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.96 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.99 |
| Quick ratio | N/A |